CureVac NV (CVAC)
2.54
+0.05
(+2.01%)
USD |
NASDAQ |
Nov 21, 14:16
CureVac Market Cap: 569.82M for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 558.60M |
| November 19, 2024 | 560.85M |
| November 18, 2024 | 578.79M |
| November 15, 2024 | 569.82M |
| November 14, 2024 | 598.98M |
| November 13, 2024 | 616.93M |
| November 12, 2024 | 646.09M |
| November 11, 2024 | 625.90M |
| November 08, 2024 | 637.12M |
| November 07, 2024 | 634.88M |
| November 06, 2024 | 641.61M |
| November 05, 2024 | 657.31M |
| November 04, 2024 | 607.96M |
| November 01, 2024 | 619.17M |
| October 31, 2024 | 614.69M |
| October 30, 2024 | 628.15M |
| October 29, 2024 | 648.34M |
| October 28, 2024 | 634.88M |
| October 25, 2024 | 616.93M |
| October 24, 2024 | 610.20M |
| October 23, 2024 | 605.71M |
| October 22, 2024 | 616.93M |
| October 21, 2024 | 621.42M |
| October 18, 2024 | 628.15M |
| October 17, 2024 | 632.63M |
| Date | Value |
|---|---|
| October 16, 2024 | 637.12M |
| October 15, 2024 | 630.39M |
| October 14, 2024 | 632.63M |
| October 11, 2024 | 652.82M |
| October 10, 2024 | 643.85M |
| October 09, 2024 | 652.82M |
| October 08, 2024 | 648.34M |
| October 07, 2024 | 668.53M |
| October 04, 2024 | 677.50M |
| October 03, 2024 | 664.04M |
| October 02, 2024 | 673.01M |
| October 01, 2024 | 666.28M |
| September 30, 2024 | 659.55M |
| September 27, 2024 | 672.94M |
| September 26, 2024 | 677.43M |
| September 25, 2024 | 686.40M |
| September 24, 2024 | 715.56M |
| September 23, 2024 | 693.13M |
| September 20, 2024 | 724.53M |
| September 19, 2024 | 737.99M |
| September 18, 2024 | 737.99M |
| September 17, 2024 | 735.75M |
| September 16, 2024 | 733.51M |
| September 13, 2024 | 771.64M |
| September 12, 2024 | 693.13M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
518.15M
Minimum
Apr 25 2024
24.58B
Maximum
Dec 09 2020
5.515B
Average
2.221B
Median
Market Cap Benchmarks
| BioNTech SE | 25.43B |
| Bayer AG | 20.02B |
| Affimed NV | 43.77M |
| InflaRx NV | 122.48M |
| Immatics NV | 929.86M |
Market Cap Related Metrics
| PE Ratio | 4.631 |
| PS Ratio | 0.9558 |
| Price to Book Value | 0.7040 |
| Price to Free Cash Flow | 5.348 |
| Price | 2.54 |
| Earnings Yield | 21.59% |
| Operating PE Ratio | 3.871 |
| Normalized PE Ratio | 4.772 |